Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clarithromycin/clofazimine/rifabutin companion diagnostic - RedHill Biopharma/Quest Diagnostics

Next Previous
Drug Profile

Clarithromycin/clofazimine/rifabutin companion diagnostic - RedHill Biopharma/Quest Diagnostics

Alternative Names: RHB 104 companion diagnostic

Latest Information Update: 06 Oct 2020

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator RedHill Biopharma
  • Class Diagnostic agents
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Crohn's disease
  • Phase II Multiple sclerosis

Most Recent Events

  • 06 Oct 2020 Phase III development in Crohn's disease (Diagnosis) is still ongoing in USA, Canada, New Zealand, Australia, Bulgaria, Czech Republic, Poland, Serbia, Slovakia and Israel (NCT01951326)
  • 05 Sep 2017 Phase-III development is ongoing in USA, Canada, New Zealand, Australia, Bulgaria, Czech Republic, Poland, Serbia, Slovakia and Israel (NCT01951326)
  • 06 Oct 2016 RedHill Biopharma collaborates with Baylor College of Medicine to develop companion diagnostic for the fixed dose combination of clarithromycin/clofazimine/rifabutin

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top